The global smart blood pressure monitoring devices market size was estimated at around USD 998.3 million in 2021 and it is projected to hit around USD 2.7 billion by 2030, growing at a CAGR of 11.2% from 2022 to 2030.
The rising prevalence of chronic diseases and increasing penetration of home healthcare services & remote use of devices are the key factors driving the product demand. The demand for smart blood pressure monitoring devices is projected to witness a rise during the forecast period due to the high adoption rate.
The COVID-19 pandemic had disrupted the transportation and supply chain of the product in the market due to the restrictions imposed by the government. As the demand for the devices increased for medical purposes to fight against COVID-19, the supply of the product also increased. COVID-19 led to an increase in demand and need for blood pressure monitors. Hence, the market players have also increased the production and supply of the devices with a competitive price in the market.
The growing aging population and rising healthcare awareness among the people have boosted the market for wearable devices. The increasing incidence of hypertension has led to rising demand for cost-effective, rapid, and accurate diagnostic solutions. Smart blood pressure monitoring devices are one of the vital signs monitors of life which can be used remotely. The cost-effective and accurate results offered by these indicators are one of the key factors responsible for market growth.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 998.3 Million |
Revenue Forecast by 2030 | USD 2.7 Billion |
Growth rate from 2022 to 2030 | CAGR of 11.2% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Phase, study design, therapeutic areas, region |
Companies Covered | Omron Healthcare, Inc; Koninklijke Philips N.V.; Qardio, Inc.; iHealth Labs Inc.; ForaCare Suisse AG; Welch Allyn; A&D Medical Inc.; Beurer GmbH; Microlife AG; Withings; Kaz Inc.; SunTech Medical, Inc. |
Type Insights
The upper arm blood pressure monitor segment dominated the market for smart blood pressure monitoring devices and accounted for the largest revenue share of more than 60.6% in 2021 as it is the most accurate form of device used to monitor blood pressure. This device can be easily operated by consumers at home with a reliable result. The wrist blood pressure monitor segment generated the second-highest revenue in 2021 and is expected to witness the highest growth rate over the forecast period due to the rising awareness about health and fitness among the people.
The wrist blood pressure monitoring devices is the most convient and easy to use device. The accuracy of the device vary in different product as per the technology used in the device. A person can carry the device and can check the blood pressure from any remote place without any assistance. However, the American Heart Association recommends using a home blood pressure monitor that measures blood pressure in upper arm and not using wrist or finger blood pressure monitors.
Technology Insights
The Bluetooth based segment dominated the market for smart blood pressure monitoring devices and accounted for the maximum revenue share of more than 76.6% in 2021 as most of the blood pressure monitor devices are based on blueooth connectivity and people are still not aware of Wi-Fi based devices. These devices are easy to use and compact, and gives the option of transferring results via Bluetooth to a smartphone, or laptop to ensure more thorough follow-up care for the patient.
The wi-fi based/4G segment is expected to witness the growth rate of 15.9% over the forecast period as Wi-Fi based blood pressure monitor provides medically accurate and reliable blood pressure and heart rate measurements with immediate feedback on the device and full history in the app which can also be linked with various health programs.
Regional Insights
North America dominated the smart blood pressure monitoring devices market and accounted for the maximum revenue share of more than 41.2% in 2021. as it has a highly regulated and developed healthcare infrastructure. Increasing investments in the development of accurate and effective blood pressure monitoring devices are expected to contribute to the regional market growth in the coming years. Moreover, new product launches, along with technological advancements, are expected to fuel the growth of the market for smart blood pressure monitoring devices.
In Asia Pacific, the market for smart blood pressure monitoring devicesis expected to register the fastest growth rate over the forecast period. The presence of untapped opportunities, increasing investments by manufacturers, growing awareness levels, and rising incidences of hypertension. Rapidly improving healthcare facilities and the rising number of undiagnosed and untreated cases of high blood pressure are the key factors contributing to the regional market growth.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Smart Blood Pressure Monitoring Devices Market
5.1. COVID-19 Landscape: Smart Blood Pressure Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Smart Blood Pressure Monitoring Devices Market, By Type
8.1. Smart Blood Pressure Monitoring Devices Market, by Type Type, 2022-2030
8.1.1. Upper Arm Blood Pressure Monitor
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Wrist Blood Pressure Monitor
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Finger Blood Pressure Monitor
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Smart Blood Pressure Monitoring Devices Market, By Technology
9.1. Smart Blood Pressure Monitoring Devices Market, by Technology, 2022-2030
9.1.1. Wi-Fi Based/4G
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Bluetooth Based
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Smart Blood Pressure Monitoring Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Technology (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Technology (2017-2030)
Chapter 11. Company Profiles
11.1. Omron Healthcare, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Koninklijke Philips N.V.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. iHealth Labs Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ForaCare Suisse AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Welch Allyn
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. A&D Medical Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Beurer GmbH
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Microlife AG
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Withings
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10.Kaz Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11.SunTech Medical, Inc.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms